ArticleProceedings of the National Academy of Sciences of the United States of America2025

Correction for Huseby et al., Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.